Organoids are 3D structures of multiple cell types derived from stem cells or patient samples. Unlike traditional 2D cell culture models, organoids can replicate much of the complex structural and functional characteristics of the parent organ, including cell-cell interactions and heterogeneity. This provides a more accurate and reproducible model for disease modelling and drug screening, that can complement or even eliminate the need for animal models. For this reason, the FDA has recently authorised the use of organoids or organ-on-a-chip models as an alternative to animal testing in the drug development process.  

Integrated capabilities for streamlined organoid culture

Whether your interest is in developing a new therapeutic, understanding developmental biology or investigating precision treatment approaches, find out how our capabilities can accelerate your research. 

Our facilities integrate advanced biomanufacturing with robotics and artificial intelligence to make organoid culture accessible and reproducible. Through our suite of automated platforms, a range of pluripotent stem cell (PSC) and patient derived organoids can be produced at scale for downstream analysis and testing.